Dr Kislay Roy




Filter by


Recent advances in nanomedicine and survivin targeting in brain cancers

J Mazur, K Roy, J Kanwar

(2018), Vol. 13, pp. 105-137, Nanomedicine (London, England), London, Eng., C1


EpCAM immunotherapy versus specific targeted delivery of drugs

Joanna Macdonald, Justin Henri, Kislay Roy, Emma Hays, Michelle Bauer, Rakesh Veedu, Normand Pouliot, Sarah Shigdar

(2018), Vol. 10, pp. 1-13, Cancers, Basel, Switzerland, C1


Topical ophthalmic formulation of Trichostatin A and SurR9-C84A for quick recovery post-alkali burn of corneal haze

K Roy, C Cheung, R Kanwar, R Sandhir, J Kanwar

(2017), Vol. 8, pp. 1-15, Experimental pharmacology and drug discovery, Lausanne, Switzerland, C1


Characterization and molecular mechanism of peptide-conjugated gold nanoparticle inhibiting p53-HDM2 interaction in retinoblastoma

S Kalmodia, S Parameswaran, K Ganapathy, W Yang, C Barrow, J Kanwar, K Roy, M Vasudevan, K Kulkarni, S Elchuri, S Krishnakumar

(2017), Vol. 9, pp. 349-364, Molecular therapy - nucleic acids, Amsterdam, The Netherlands, C1


Biodegradable Eri silk nanoparticles as a delivery vehicle for bovine lactoferrin against MDA-MB-231 and MCF-7 breast cancer cells

K Roy, Y Patel, R Kanwar, R Rajkhowa, X Wang, J Kanwar

(2016), Vol. 11, pp. 25-44, International journal of nanomedicine, Macclesfield, Eng., C1


Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents

R Chaudhary, K Roy, R Kanwar, K Walder, J Kanwar

(2016), Vol. 14, pp. 1-17, Journal of nanobiotechnology, London, Eng., C1


Comparative activities of milk components in reversing chronic colitis

J Kanwar, R Kanwar, S Stathopoulos, N Haggarty, A MacGibbon, K Palmano, K Roy, A Rowan, G Krissansen

(2016), Vol. 99, pp. 2488-2501, Journal of dairy science, Atlanta, Ga., C1


Survivin modulators: an updated patent review (2011-2015)

K Roy, N Singh, R Kanwar, J Kanwar

(2016), Vol. 11, pp. 152-169, Recent patents on anti-cancer drug discovery, Beijing, China, C1


Theranostic multimodular potential of zinc-doped ferrite-saturated metal-binding protein-loaded novel nanocapsules in cancers

S Kamalapuram, R Kanwar, K Roy, R Chaudhary, R Sehgal, J Kanwar

(2016), Vol. 11, pp. 1349-1366, International journal of nanomedicine, Macclesfield, Eng., C1


Ophthalmic combination of SurR9-C84A and trichostatin-A targeting molecular pathogenesis of alkali burn

K Roy, B Sriramoju, R Kanwar, J Kanwar

(2016), Vol. 7, pp. 1-14, Frontiers in Pharmacology, Lausanne, Switzerland, C1


E-cadherin aptamer-conjugated delivery of doxorubicin for targeted inhibition of prostate cancer cells

R Chaudhary, K Roy, R Kanwar, R Veedu, S Krishnakumar, C Cheung, A Verma, J Kanwar

(2016), Vol. 69, pp. 1108-1116, Australian journal of chemistry, Clayton, Vic., C1


Fe-bLf nanoformulation targets survivin to kill colon cancer stem cells and maintains absorption of iron, calcium and zinc

J Kanwar, V Mahidhara, K Roy, S Sasidharan, S Krishnakumar, N Prasad, R Sehgal, R Kanwar

(2015), Vol. 10, pp. 35-55, Nanomedicine, London, United Kingdom, C1


Competitive inhibition of survivin using a cell-permeable recombinant protein induces cancer-specific apoptosis in colon cancer model

K Roy, R Kanwar, S Krishnakumar, C Cheung, J Kanwar

(2015), Vol. 10, pp. 1019-1043, International journal of nanomedicine, Auckland, N. Z., C1


Nucleic acid-based aptamers: applications, development and clinical trials

J Kanwar, K Roy, N Maremanda, K Subramanian, R Veedu, R Bawa, R Kanwar

(2015), Vol. 22, pp. 2539-2557, Current medicinal chemistry, Bussum, The Netherlands, C1


Evaluation of nanoformulated therapeutics in an ex-vivo bovine corneal irritation model

B Sriramoju, K Roy, R Kanwar, J Kanwar

(2015), Vol. 29, pp. 917-925, Toxicology in vitro, Amsterdam, The Netherlands, C1


Locked nucleic acid modified bi-specific aptamer-targeted nanoparticles carrying survivin antagonist towards effective colon cancer therapy

K Roy, R Kanwar, C Antonio Cheung, C Lee Fleming, R Veedu, S Krishnakumar, J Kanwar

(2015), Vol. 5, pp. 29008-29016, RSC advances, Cambridge, Eng., C1


Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions

J Kanwar, K Roy, Y Patel, S-F Zhou, M Singh, D Singh, M Nasir, R Sehgal, A Sehgal, R Singh, S Garg, R Kanwar

(2015), Vol. 20, pp. 9703-9731, Molecules, Basel, Switzerland, C1-1


Targeting VEGF with LNA-stabilized G-rich oligonucleotide for efficient breast cancer inhibition

S Edwards, V Poongavanam, J Kanwar, K Roy, K Hillman, N Prasad, R Leth-Larsen, M Petersen, M Maru?i?, J Plavec, J Wengel, R Veedu

(2015), Vol. 51, pp. 9499-9502, Chemical Communications, London, Eng., C1


Oral administration of iron-saturated bovine lactoferrin-loaded ceramic nanocapsules for breast cancer therapy and influence on iron and calcium metabolism

G Mahidhara, R Kanwar, K Roy, J Kanwar

(2015), Vol. 10, pp. 4081-4098, International journal of nanomedicine, Auckland, N. Z., C1


LNA aptamer based multi-modal, Fe3O4-saturated lactoferrin (Fe3O4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging

K Roy, R Kanwar, J Kanwar

(2015), Vol. 71, pp. 84-99, Biomaterials, Amsterdam, The Netherlands, C1


Molecular targets in arthritis and recent trends in nanotherapy

K Roy, R Kanwar, J Kanwar

(2015), Vol. 10, pp. 5407-5420, International journal of nanomedicine, Auckland, N. Z., C1


Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells

N Maremanda, K Roy, R Kanwar, V Shyamsundar, V Ramshankar, A Krishnamurthy, S Krishnakumar, J Kanwar

(2015), Vol. 9, pp. 1-20, Biomicrofluidics, Maryland, United States, C1


Bioceramic nanomaterials in medical applications

J Kanwar, G Mahidhara, K Roy, R Kanwar

(2014), pp. 163-175, Bioengineered nanomaterials, Boca Raton, Flo., B1


Chimeric aptamers in cancer cell-targeted drug delivery

J Kanwar, K Roy, R Kanwar

(2011), Vol. 46, pp. 459-477, Critical reviews in biochemistry and molecular biology, London, England, C1


Applications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseases

J Kanwar, R Mohan, R Kanwar, K Roy, R Bawa

(2010), Vol. 5, pp. 1435-1445, Nanomedicine, London, England, C1


Funded Projects at Deakin

No Funded Projects at Deakin found


Associate Supervisor

Mohamed Ayman Abdelhamid Abdel Aboda

Thesis entitled: Multimodal Therapy and Molecular Exosomal-microRNA Biomarkers for Cancer Cachexia

Doctor of Philosophy (Medicine), School of Medicine